ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2023

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.

Arielle Elkrief et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.